LakeShore Biopharma Co Ltd (FRA:H6Z0) Stock Price, Trades & News

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Financial Strength

3/10

	Name	Current	Vs Industry		Vs History

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

	Name	Current	Vs Industry		Vs History
	5-Day RSI	56.35
	9-Day RSI	51.25
	14-Day RSI	47.9
	3-1 Month Momentum %	-18.13
	6-1 Month Momentum %	-66.75
	12-1 Month Momentum %	-90.3

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History

Profitability Rank

2/10

	Name	Current	Vs Industry		Vs History
	FCF Margin %	-27.72
	OCF Margin %	-24.35

GF Value Rank

	Name	Current	Vs Industry		Vs History
	Forward PE Ratio	5.59
	EV-to-Forward-Revenue	1.39

Financials (Next Earnings Date:2026-07-31 Est.)

Annual Quarterly TTM

FRA:H6Z0's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

LakeShore Biopharma Co Ltd Executives

Details

GF Value™

FRA:H6Z0

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected issues with H6Z0. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	78.369
	EPS (TTM) (€)	-0.666
	Beta	-
	3-Year Sharpe Ratio	-
	3-Year Sortino Ratio	-
	Volatility %	91.2
	14-Day RSI	47.9
	14-Day ATR (€)	0.028003
	20-Day SMA (€)	0.6575
	12-1 Month Momentum %	-90.3
	52-Week Range (€)	0.4918 - 6.75
	Shares Outstanding (Mil)	41.21

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	0
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

LakeShore Biopharma Co Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

LakeShore Biopharma Co Ltd Stock Events

Financials Calendars

Event	Date	Price (€)
Second quarter earnings results for 2027	2026-11-13	In 105 days
First quarter earnings conference call for 2027	2026-08-14	In 14 days
First quarter earnings results for 2027	2026-08-14	In 14 days
Annual report for 2026	2026-07-31	0.67 (+0.00%)
Fourth quarter earnings results for 2026	2026-07-31	0.67 (+0.00%)
General meeting for 2025	2026-06-29	0.67 (+0.00%)
Second quarter earnings results for 2026	2025-12-19	0.67 (+0.00%)
General meeting for 2024	2025-10-20	0.67 (+0.00%)
First quarter earnings conference call for 2026	2025-10-03	0.67 (+0.00%)
First quarter earnings results for 2026	2025-10-03	0.67 (+0.00%)

Show

Entries

LakeShore Biopharma Co Ltd Frequently Asked Questions

What is LakeShore Biopharma Co Ltd(FRA:H6Z0)'s stock price today?

The current price of FRA:H6Z0 is €0.67. The 52 week high of FRA:H6Z0 is €6.75 and 52 week low is €0.49.

When is next earnings date of LakeShore Biopharma Co Ltd(FRA:H6Z0)?

The next earnings date of LakeShore Biopharma Co Ltd(FRA:H6Z0) is 2026-07-31 Est..

Does LakeShore Biopharma Co Ltd(FRA:H6Z0) pay dividends? If so, how much?

LakeShore Biopharma Co Ltd(FRA:H6Z0) does not pay dividend.

Press Release

	Subject	Date
	LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company	2026-03-25
	LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders	2026-02-06
	LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders	2026-01-20
	LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction	2025-11-04
	LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting	2025-09-22
	LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq	2025-09-12
	LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee	2025-09-10
	LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee	2025-08-28
	LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company	2025-08-18
	LakeShore Biopharma Announces Fiscal Year 2025 Financial Results	2025-07-31

10/Page

Articles on LakeShore Biopharma Co Ltd

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.